The use of in vitro immunisation, as an adjunct to monoclonal antibody production, may result in the production of hybridomas secreting polyreactive antibodies-Reference-Cited by-同舟云学术

The use of in vitro immunisation, as an adjunct to monoclonal antibody production, may result in the production of hybridomas secreting polyreactive antibodies

Published:2001-12 Issue:1-2 Volume:258 Page:27-36
ISSN:0022-1759
Container-title:Journal of Immunological Methods
language:en
Short-container-title:Journal of Immunological Methods

Author:

McMahon Michael J,O'Kennedy Richard

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference32 articles.

1. Natural autoantibodies: the other side of the immune system;Avrameas;Res. Immunol.,1995

2. Heavy chain variable gene usage by human B-1 lymphocytes and polyreactive autoantibodies;Bhat;Hum. Antibodies,1997

3. Production of murine monoclonal antibodies against sulcofuron and flucofuron by in vitro immunisation;Bonwick;J. Immunol. Methods,1996

4. In vitro immunisation for production of murine and human monoclonal antibodies: present status;Borrebaeck;Trends Biotechnol.,1986

5. Critical appraisal of the in vitro immunisation technique for the production of mouse and human monoclonal antibodies;Borrebaeck;Adv. Drug Delivery Rev.,1988

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Generation of Mouse Monoclonal Antibodies Specific to Chikungunya Virus Using ClonaCell-HY Hybridoma Cloning Kit;Methods in Molecular Biology;2016

2. Surface plasmon resonance imaging detection of silver nanoparticle-tagged immunoglobulin;Journal of The Royal Society Interface;2011-02-16

3. Polyreactivity of Monoclonal Antibodies Made Against Human Erythrocyte Membranes with Various Pathogenic Bacteria;Hybridoma;2011-02

4. Hybridoma Generation by In Vitro Immunization of Murine Splenocytes with Cytosolic Proteins of Chinese Hamster Ovary (CHO) Mitotic Cells;Hybridoma;2007-10

5. Antigen-Based Immunofluorescence Analysis of B-Cell Targeting: Advanced Technology for the Generation of Novel Monoclonal Antibodies with High Efficiency and Selectivity;Hybridoma;2006-10